I postulated this delay in the thread earlier and...

I postulated this delay in the thread earlier and @BoomCrashOffera was of the opinion this was to allow for pre trial work to be finalised.

I certainly hope you’re correct and there’s more to come. I’ve only been invested for a fraction of the time you and others have been in but this is the most dejected I’ve seen the sentiment here since joining. I hope that it bodes well and that we are sitting in a calculated silence from management with elucidations and new indications to come.

Do we expect the murdoch results and FDA clarification by EOY? I’m cautiously optimistic that this is the case given Mark’s recent tendency to emphasise the TAM of inflam and DMD AND refer to the roche-sarepta market size. But the ongoing games with the SP has left me somewhat hesitant to engage in any hope in the short term, albeit still waiting for the long term game plan to pan out.